Literature DB >> 21892192

Effects of the histamine H(1) receptor antagonist hydroxyzine on hERG K(+) channels and cardiac action potential duration.

Byung Hoon Lee1, Seung Ho Lee, Daehyun Chu, Jin Won Hyun, Han Choe, Bok Hee Choi, Su-Hyun Jo.   

Abstract

AIM: To investigate the effects of hydroxyzine on human ether-a-go-go-related gene (hERG) channels to determine the electrolphysiological basis for its proarrhythmic effects.
METHODS: hERG channels were expressed in Xenopus oocytes and HEK293 cells, and the effects of hydroxyzine on the channels were examined using two-microelectrode voltage-clamp and patch-clamp techniques, respectively. The effects of hydroxyzine on action potential duration were examined in guinea pig ventricular myocytes using current clamp.
RESULTS: Hydroxyzine (0.2 and 2 μmol/L) significantly increased the action potential duration at 90% repolarization (APD(90)) in both concentration- and time-dependent manners. Hydroxyzine (0.03-3 μmol/L) blocked both the steady-state and tail hERG currents. The block was voltage-dependent, and the values of IC(50) for blocking the steady-state and tail currents at +20 mV was 0.18±0.02 μmol/L and 0.16±0.01 μmol/L, respectively, in HEK293 cells. Hydroxyzine (5 μmol/L) affected both the activated and the inactivated states of the channels, but not the closed state. The S6 domain mutation Y652A attenuated the blocking of hERG current by ~6-fold.
CONCLUSION: The results suggest that hydroxyzine could block hERG channels and prolong APD. The tyrosine at position 652 in the channel may be responsible for the proarrhythmic effects of hydroxyzine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892192      PMCID: PMC4003299          DOI: 10.1038/aps.2011.66

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  29 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  A novel hypothesis for the binding mode of HERG channel blockers.

Authors:  Han Choe; Kwang Hoon Nah; Soo Nam Lee; Han Sam Lee; Hui Sun Lee; Su Hyun Jo; Chae Hun Leem; Yeon Jin Jang
Journal:  Biochem Biophys Res Commun       Date:  2006-03-31       Impact factor: 3.575

3.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

4.  "Conventional" antihistamines slow cardiac repolarization in isolated perfused (Langendorff) feline hearts.

Authors:  W X Wang; S N Ebert; X K Liu; Y W Chen; M D Drici; R L Woosley
Journal:  J Cardiovasc Pharmacol       Date:  1998-07       Impact factor: 3.105

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Authors:  S Rajamani; L L Eckhardt; C R Valdivia; C A Klemens; B M Gillman; C L Anderson; K M Holzem; B P Delisle; B D Anson; J C Makielski; C T January
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

7.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Block of HERG k channel by classic histamine h(1) receptor antagonist chlorpheniramine.

Authors:  Hee-Kyung Hong; Su-Hyun Jo
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

9.  Cardiotoxic potential and CNS effects of first-generation antihistamines.

Authors:  M Taglialatela; H Timmerman; L Annunziato
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

Review 10.  Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications.

Authors:  M Taglialatela; P Castaldo; A Pannaccione; G Giorgio; L Annunziato
Journal:  Biochem Pharmacol       Date:  1998-06-01       Impact factor: 5.858

View more
  3 in total

1.  QT prolongation induced by hydroxyzine: a pharmacovigilance case report.

Authors:  Jonathan Vigne; Joachim Alexandre; Fabienne Fobe; Paul Milliez; Magalie Loilier; Sophie Fedrizzi; Antoine Coquerel
Journal:  Eur J Clin Pharmacol       Date:  2015-01-28       Impact factor: 2.953

2.  Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re-evaluation of an established drug.

Authors:  Anne-Françoise Schlit; Annie Delaunois; Aurore Colomar; Branderley Claudio; Luca Cariolato; Rossen Boev; Jean-Pierre Valentin; Christopher Peters; Victor S Sloan; Jürgen W G Bentz
Journal:  Pharmacol Res Perspect       Date:  2017-04-21

Review 3.  Cardiovascular safety of antihistamines.

Authors:  Anna Olasińska-Wiśniewska; Jerzy Olasiński; Stefan Grajek
Journal:  Postepy Dermatol Alergol       Date:  2014-06-13       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.